High tumor rate found in secondary azoospermia cases

Seattle-A retrospective review of patients with secondary azoospermia has uncovered an alarming tumor rate and a high sperm recovery rate, reiterating the importance of urologic evaluation in this population.

Related Content:

Female Urology

Trial enrollment for uUTI drug stopped early after primary outcome for efficacy was reached

AUGS Clinical Meeting 2022, Beyond Urogynecology: Pearls for Best Practice | October 13-15

FDA says oral UTI treatment application is insufficient for approval